论文信息 - 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

[1] David R Thompson,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[2] Rod S Taylor,et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. , 2016, Journal of the American College of Cardiology.

[3] G. Lip,et al. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. , 2015, European heart journal.

[4] C. V. van Mieghem,et al. Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5] Christian Schindler,et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. , 2015, The American journal of medicine.

[6] Sunil V. Rao,et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial , 2015, The Lancet.

[7] Improve-It Investigators. Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .

[8] Peter Cameron,et al. Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction , 2015, Circulation.

[9] Michael Freese,et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction , 2015, Circulation.

[10] Walter Desmet,et al. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. , 2015, European heart journal.

[11] Ò. Miró,et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay , 2015, Canadian Medical Association Journal.

[12] Marc P. Bonaca,et al. Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.

[13] H. Schunkert,et al. Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial. , 2015, Journal of the American College of Cardiology.

[14] G. Lip,et al. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials , 2015, BMJ : British Medical Journal.

[15] C. Patrono,et al. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs. , 2015, Biochimica et biophysica acta.

[16] J. Wetterslev,et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis , 2015, BMJ : British Medical Journal.

[17] S. Windecker,et al. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. , 2015, JAMA.

[18] G. Angelini,et al. Liberal or restrictive transfusion after cardiac surgery. , 2015, The New England journal of medicine.

[19] M. Valgimigli,et al. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. , 2015, Journal of the American College of Cardiology.

[20] J. Wójcik,et al. 6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. , 2015, Journal of the American College of Cardiology.

[21] J. Carrero,et al. Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. , 2015, JAMA.

[22] P. Doherty,et al. Challenges in secondary prevention of cardiovascular diseases: a review of the current practice. , 2015, International journal of cardiology.

[23] Morwenna Rogers,et al. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis , 2015, BMJ : British Medical Journal.

[24] O. Senn,et al. Diagnostic performance of reproducible chest wall tenderness to rule out acute coronary syndrome in acute chest pain: a prospective diagnostic study , 2015, BMJ Open.

[25] S. Blankenberg,et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study , 2014, European heart journal.

[26] R. Califf,et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. , 2015, The New England journal of medicine.

[27] Braunwald,et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.

[28] P. Kirchhof,et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association , 2014, European heart journal.

[29] C. Hengstenberg,et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. , 2014, JAMA.

[30] G. Montalescot,et al. Pretreatment with P2Y12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy , 2014, Circulation.

[31] Antonio Colombo,et al. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. , 2014, Journal of the American College of Cardiology.

[32] Robert Dressler,et al. Altering overuse of cardiac telemetry in non-intensive care unit settings by hardwiring the use of American Heart Association guidelines. , 2014, JAMA internal medicine.

[33] E. Vicaut,et al. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial , 2014, The Lancet.

[34] E. Omerovic,et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. , 2014, The New England journal of medicine.

[35] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[36] H. White,et al. Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. , 2014, American heart journal.

[37] Brian J. McCourt,et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. , 2014, JACC. Cardiovascular interventions.

[38] J. Beyer-Westendorf,et al. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. , 2014, European heart journal.

[39] R. Ljung,et al. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. , 2014, Journal of the American College of Cardiology.

[40] A. Go,et al. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction. , 2014, Journal of the American College of Cardiology.

[41] G. Lippi,et al. The concentration of troponin I is increased in patients with acute-onset atrial fibrillation. , 2014, International journal of cardiology.

[42] S. de Servi,et al. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial , 2014, European heart journal. Acute cardiovascular care.

[43] M. Sebbane,et al. A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. , 2014, The American journal of cardiology.

[44] Robert H Christenson,et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. , 2014, Journal of the American College of Cardiology.

[45] C. Cannon,et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial , 2014, European heart journal.

[46] Alana D. Steffen,et al. Sensitivity, Specificity, and Sex Differences in Symptoms Reported on the 13‐Item Acute Coronary Syndrome Checklist , 2014, Journal of the American Heart Association.

[47] Daniel E Forman,et al. Frailty assessment in the cardiovascular care of older adults. , 2014, Journal of the American College of Cardiology.

[48] C. Mueller. Biomarkers and acute coronary syndromes: an update. , 2014, European heart journal.

[49] P. Collinson,et al. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis , 2014, European heart journal. Acute cardiovascular care.

[50] R. Califf,et al. Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients , 2014, European heart journal. Acute cardiovascular care.

[51] C. Hesse,et al. Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. , 2014, British journal of anaesthesia.

[52] E. Peterson,et al. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. , 2014, JAMA.

[53] R. Twerenbold,et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. , 2014, European heart journal.

[54] K. Denhaerynck,et al. Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction. , 2014, JAMA internal medicine.

[55] D. Chew,et al. An examination of clinical intuition in risk assessment among acute coronary syndromes patients: observations from a prospective multi-center international observational registry. , 2014, International journal of cardiology.

[56] Pierre Coste,et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score , 2014, BMJ Open.

[57] C. Held,et al. Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2014, Circulation.

[58] M. Jeong,et al. Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Randomized, Controlled Trial , 2014, Circulation.

[59] S. Windecker,et al. Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[60] P. Andersen,et al. Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark , 2014, BMJ Open.

[61] D. Atar,et al. High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial , 2013, Circulation.

[62] K. Huber,et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention , 2013, European heart journal.

[63] Hugo A. Katus,et al. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction , 2013, European heart journal.

[64] K. Rentsch,et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. , 2013, European heart journal.

[65] B. Gorenek,et al. ESC / ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management , 2014 .

[66] CarloPatrono,et al. Nonsteroidal Anti-Inflammatory Drugs and the Heart , 2014 .

[67] MarcoValgimigli. Pretreatment With P2Y12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified , 2014 .

[68] Seung‐Jung Park,et al. Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study. , 2014, American heart journal.

[69] K. Werdan,et al. Kardiogener Schock , 2014, Deutsche Medizinische Wochenschrift.

[70] J. Zamorano,et al. The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. , 2014, European heart journal. Acute cardiovascular care.

[71] J. Marchesini,et al. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplas , 2014, JACC. Cardiovascular interventions.

[72] Jeroen J. Bax,et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[73] A. Kastrati,et al. Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention , 2014, Journal of Thrombosis and Thrombolysis.

[74] R. Prager,et al. Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. , 2014, The Annals of thoracic surgery.

[75] Deepak L. Bhatt,et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. , 2013, JAMA.

[76] Deepak L. Bhatt,et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data , 2013, The Lancet.

[77] P. Serruys,et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials , 2013, The Lancet.

[78] A. Kastrati,et al. Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction. , 2013, Journal of interventional cardiology.

[79] V. Fuster,et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. , 2013, The lancet. Diabetes & endocrinology.

[80] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.

[81] H. Ashrafian,et al. The effect of off-pump coronary artery bypass on mortality after acute coronary syndrome: a meta-analysis. , 2013, International journal of cardiology.

[82] G. Schuler,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[83] Mario Fusaro,et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis , 2013, BMJ.

[84] C. Vilaplana,et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. , 2013, International journal of cardiology.

[85] M. Hawn,et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. , 2013, JAMA.

[86] C. Reid,et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. , 2013, Journal of the American College of Cardiology.

[87] V. Fuster,et al. Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. , 2013, International journal of cardiology.

[88] T. Chua,et al. Stress myocardial perfusion imaging for the evaluation and triage of chest pain in the emergency department: A randomized controlled trial , 2013, Journal of Nuclear Cardiology.

[89] E. Vicaut,et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. , 2013, The New England journal of medicine.

[90] L. Køber,et al. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. , 2013, Journal of the American College of Cardiology.

[91] J. Hodges,et al. Long-term survival in patients with refractory angina. , 2013, European heart journal.

[92] B. Lewis,et al. Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial , 2013, Circulation.

[93] E. Hess,et al. Triple rule-out computed tomographic angiography for chest pain: a diagnostic systematic review and meta-analysis. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[94] H. Schunkert,et al. Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. , 2013, American heart journal.

[95] X. Y. Zhang,et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials , 2013, BDJ.

[96] V. Roger. Epidemiology of Heart Failure , 2013, Circulation research.

[97] Peter L Duffy,et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.

[98] J. Ambrose,et al. Frequency of Takotsubo cardiomyopathy in postmenopausal women presenting with an acute coronary syndrome. , 2013, The American journal of cardiology.

[99] A. Kastrati,et al. Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention , 2013, Circulation. Cardiovascular interventions.

[100] David Brieger,et al. Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes. , 2013, American heart journal.

[101] S. Maes,et al. Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.

[102] J. Kirklin. Long-term mechanical circulatory support: could it really have a public health impact? , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[103] B. Uretsky,et al. Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data , 2013, Journal of the American Heart Association.

[104] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[105] M. Mack,et al. Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score , 2013, Circulation.

[106] A. Jaffe,et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). , 2013, Journal of the American College of Cardiology.

[107] J. George,et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. , 2013, Transfusion medicine reviews.

[108] C. Vilaplana,et al. Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. , 2013, American heart journal.

[109] E. Braunwald,et al. Unstable Angina: Is It Time for a Requiem? , 2013, Circulation.

[110] G. Lip,et al. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. , 2013, European heart journal.

[111] S. Takanashi,et al. Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris. , 2013, The Journal of thoracic and cardiovascular surgery.

[112] R. Giugliano,et al. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. , 2013, American heart journal.

[113] G. Wang,et al. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. , 2013, JAMA surgery.

[114] S. Sasaki,et al. Presentations of acute coronary syndrome related to coronary lesion morphologies as assessed by intravascular ultrasound and optical coherence tomography. , 2013, International journal of cardiology.

[115] P. Libby. Mechanisms of acute coronary syndromes and their implications for therapy. , 2013, The New England journal of medicine.

[116] Nobuhiro Tanaka,et al. Functional assessment of coronary stenoses: can we live without it? , 2013, European heart journal.

[117] M. Mack,et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[118] Gregg W Stone,et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. , 2013, The New England journal of medicine.

[119] W. Qiu,et al. Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review. , 2013, American heart journal.

[120] P. Conley,et al. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa , 2013, Nature Medicine.

[121] Tom Adriaenssens,et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[122] T. Lehr,et al. Pharmacometric Characterization of Dabigatran Hemodialysis , 2013, Clinical Pharmacokinetics.

[123] R. Senior,et al. Incremental Diagnostic and Prognostic Value of Contemporary Stress Echocardiography in a Chest Pain Unit: Mortality and Morbidity Outcomes From a Real-World Setting , 2013, Circulation. Cardiovascular imaging.

[124] N. Deshpande,et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization , 2013 .

[125] R. Twerenbold,et al. Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays. , 2013, American heart journal.

[126] Christian Pristipino,et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[127] Ri-tai Huang,et al. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[128] T. Villines,et al. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials. , 2013, Journal of the American College of Cardiology.

[129] Antonio Colombo,et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial , 2013, The Lancet.

[130] G. Stone,et al. Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes , 2013, Annals of Internal Medicine.

[131] J. Wetterslev,et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. , 2013, JAMA internal medicine.

[132] V. Fuster,et al. Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation , 2013, Journal of thrombosis and haemostasis : JTH.

[133] S. Yusuf,et al. Off-pump or on-pump coronary-artery bypass grafting. , 2012, The New England journal of medicine.

[134] D. Kansagara,et al. Treatment of Anemia in Patients With Heart Disease , 2013, Annals of Internal Medicine.

[135] B. Gersh,et al. ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[136] Ian Jenkins,et al. Nonheparin anticoagulants for heparin-induced thrombocytopenia. , 2013, The New England journal of medicine.

[137] E. V. Simon. Beta-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease , 2013 .

[138] J. Alpert,et al. How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.

[139] Akshay S. Desai,et al. Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[140] S. Kurz,et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. , 2012, The American journal of medicine.

[141] W. Winkelmayer,et al. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. , 2012, Journal of the American Society of Nephrology : JASN.

[142] E. Vicaut,et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. , 2012, The New England journal of medicine.

[143] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[144] Howard K. Song,et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. , 2012, The Annals of thoracic surgery.

[145] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[146] P. Serruys,et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.

[147] Y. Jang,et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). , 2012, Journal of the American College of Cardiology.

[148] Deepak L. Bhatt,et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. , 2012, JAMA.

[149] G. Schuler,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[150] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[151] C. Schindler,et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. , 2012, Archives of internal medicine.

[152] L. Køber,et al. Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study , 2012, Circulation.

[153] S. Raposeiras-Roubín,et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome , 2012, European heart journal. Acute cardiovascular care.

[154] S. de Servi,et al. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. , 2012, JACC. Cardiovascular interventions.

[155] Marissa Miller,et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? , 2012, The Journal of thoracic and cardiovascular surgery.

[156] L. Räber,et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.

[157] A. Kirtane,et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials , 2012, BMJ : British Medical Journal.

[158] G. Schuler,et al. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). , 2012, European heart journal.

[159] Sunil V. Rao,et al. The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. , 2012, European heart journal.

[160] Mario Plebani,et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. , 2012, European heart journal.

[161] J. Fleg,et al. Coronary CT angiography versus standard evaluation in acute chest pain. , 2012, The New England journal of medicine.

[162] M. Sabatine,et al. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2012, Journal of the American College of Cardiology.

[163] TobiasReichlin,et al. High-Sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease , 2012 .

[164] R. Califf,et al. Sustained Ventricular Tachycardia and Ventricular Fibrillation Complicating Non–ST-Segment–Elevation Acute Coronary Syndromes , 2012, Circulation.

[165] K. Denhaerynck,et al. High-Sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease , 2012, Circulation.

[166] Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis , 2012, BMC Research Notes.

[167] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[168] W. Wojakowski,et al. Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial. , 2012, The Journal of thoracic and cardiovascular surgery.

[169] M. Niemelä,et al. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention. , 2012, The American journal of cardiology.

[170] P. Serruys,et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. , 2012, Journal of the American College of Cardiology.

[171] G. Stone,et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placem , 2012, Journal of the American College of Cardiology.

[172] Deepak L. Bhatt,et al. Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials , 2012, Circulation.

[173] C. Reid,et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. , 2012, Journal of the American College of Cardiology.

[174] K. Werdan,et al. Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidence. , 2012, Artificial organs.

[175] D. Angiolillo,et al. Antithrombotic Therapy in Patients With Chronic Kidney Disease , 2012, Circulation.

[176] G. Biondi-Zoccai,et al. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[177] Edward O'Brien,et al. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial , 2012, The Lancet.

[178] R. Twerenbold,et al. Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. , 2012, The American journal of medicine.

[179] S. Yusuf,et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. , 2012, The New England journal of medicine.

[180] Marc P. Bonaca,et al. Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.

[181] C. Gatsonis,et al. CT angiography for safe discharge of patients with possible acute coronary syndromes. , 2012, The New England journal of medicine.

[182] G. Vilahur,et al. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease , 2012, European heart journal. Acute cardiovascular care.

[183] R. Roussel,et al. Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. , 2012, Archives of cardiovascular diseases.

[184] P. Rehak,et al. Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery: The Timing Based on Platelet Function Strategy to Reduce Clopidogrel-Associated Bleeding Related to CABG (TARGET-CABG) Study , 2012, Circulation. Cardiovascular interventions.

[185] G. Guyatt,et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[186] J. Marchesini,et al. Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial , 2012, Circulation.

[187] M. Hadamitzky,et al. Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention , 2012, Circulation.

[188] F. Biancari,et al. Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. , 2012, The Journal of thoracic and cardiovascular surgery.

[189] R. West,et al. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. , 2012, European heart journal.

[190] Viola Vaccarino,et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. , 2012, JAMA.

[191] D. Chew,et al. The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry , 2012, BMJ Open.

[192] J. Deckers,et al. Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes. , 2012, The American journal of cardiology.

[193] Manesh R. Patel,et al. A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department , 2012, Journal of Nuclear Cardiology.

[194] E. Vicaut,et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[195] Jeroen J. Bax,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[196] Robert L Kormos,et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[197] Mark Crowther,et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[198] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[199] M. Jeong,et al. Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study , 2012, Circulation.

[200] M. Price,et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. , 2012, JAMA.

[201] Deepak L. Bhatt,et al. Antiplatelet Therapy and Proton Pump Inhibition: Clinician Update , 2012, Circulation.

[202] Giuseppe Ambrosio,et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.

[203] Paul Burton,et al. Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[204] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[205] Maarten L. Simoons,et al. The third universal definition of myocardial infarction , 2013 .

[206] W. Ageno,et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis , 2012 .

[207] Arlene S Bierman,et al. Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. , 2012, American heart journal.

[208] D. Fintel,et al. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty. , 2012, Texas Heart Institute journal.

[209] G. Gensini,et al. [Epidemiology of Tako-tsubo cardiomyopathy: the Tuscany Registry for Tako-tsubo Cardiomyopathy ]. , 2012, Giornale italiano di cardiologia.

[210] J. Hansen. Treatment with Verapamil after an Acute Myocardial Infarction , 2012, Drugs.

[211] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[212] R. Dutton. Haemostatic resuscitation. , 2012, British journal of anaesthesia.

[213] J. Carson,et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.

[214] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[215] F. Nabi,et al. Assessing risk in acute chest pain: The value of stress myocardial perfusion imaging in patients admitted through the emergency department , 2012, Journal of Nuclear Cardiology.

[216] S. Blankenberg,et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.

[217] C. Samama,et al. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis. , 2011, Archives of cardiovascular diseases.

[218] T. Athanasiou,et al. Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. , 2011, European heart journal.

[219] V. Lorenzoni,et al. Contrast stress-echocardiography predicts cardiac events in patients with suspected acute coronary syndrome but nondiagnostic electrocardiogram and normal 12-hour troponin. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[220] R. de Caterina,et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. , 2011, European heart journal.

[221] Joy L. Johnson,et al. Gender differences in symptoms of myocardial ischaemia. , 2011, European heart journal.

[222] C. Cannon,et al. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. , 2011, European heart journal.

[223] C. Held,et al. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. , 2011, European heart journal.

[224] L. Wallentin,et al. Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). , 2011, European heart journal.

[225] P. Mody,et al. Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non – ST-Segment Elevation – Myocardial Infarction , 2012 .

[226] Jörg Hausleiter,et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. , 2011, The New England journal of medicine.

[227] Li-jun Guo,et al. The relationship between kidney function and angiographically-derived SYNTAX score. , 2011, The Canadian journal of cardiology.

[228] A. Moss,et al. Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long‐Term Survival in the MADIT‐II Trial , 2011, Journal of cardiovascular electrophysiology.

[229] M. Roffi,et al. Current concepts on coronary revascularization in diabetic patients. , 2011, European heart journal.

[230] S. Scott,et al. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. , 2011, JAMA.

[231] K. Anstrom,et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. , 2011, Journal of the American College of Cardiology.

[232] Sunil V. Rao,et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). , 2011, The American journal of cardiology.

[233] P. Kamphuisen,et al. Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects , 2011, Circulation.

[234] M. Leoncini,et al. Effects of Hydration in Contrast-Induced Acute Kidney Injury After Primary Angioplasty: A Randomized, Controlled Trial , 2011, Circulation. Cardiovascular interventions.

[235] Deepak L. Bhatt,et al. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive Summary , 2011, Circulation. Cardiovascular interventions.

[236] T. Akasaka,et al. Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina. , 2011, Journal of the American College of Cardiology.

[237] D. Berman,et al. The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. , 2011, Journal of the American College of Cardiology.

[238] D. Wood,et al. Mechanisms of Myocardial Infarction in Women Without Angiographically Obstructive Coronary Artery Disease , 2011, Circulation.

[239] Betti Giusti,et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. , 2011, JAMA.

[240] A. Jaffe,et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. , 2011, Journal of the American College of Cardiology.

[241] K. Nikus,et al. Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction. , 2011, Journal of electrocardiology.

[242] Á. Avezum,et al. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. , 2011, The American journal of cardiology.

[243] T. Lauer,et al. Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .

[244] Deepak L. Bhatt,et al. Apixaban with antiplatelet therapy after acute coronary syndrome. , 2011, The New England journal of medicine.

[245] D. Atar,et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. , 2011, European heart journal.

[246] R. Twerenbold,et al. Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction , 2011 .

[247] S. Ebrahim,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.

[248] C. Hamm,et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. , 2011, American heart journal.

[249] C. Cannon,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial , 2011, BMJ : British Medical Journal.

[250] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[251] G. Stone,et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. , 2011, Journal of the American College of Cardiology.

[252] Samin K. Sharma,et al. How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes? , 2011, Current cardiology reports.

[253] Eugene H Blackstone,et al. Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? , 2011, The Annals of thoracic surgery.

[254] Michael Freese,et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. , 2011, European heart journal.

[255] Li-sheng Liu,et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. , 2011, European heart journal.

[256] P. Ho,et al. Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®). , 2011, American heart journal.

[257] A. Bayés‐Genís,et al. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes. , 2011, European heart journal.

[258] Sunil V. Rao,et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[259] Denis Xavier,et al. Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[260] I. Olkin,et al. Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications , 2011, Annals of Internal Medicine.

[261] C. Reid,et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study , 2011, The Lancet.

[262] N. Schork,et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. , 2011, JAMA.

[263] D. Angiolillo,et al. Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome , 2011, Circulation.

[264] R. Califf,et al. Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome: An Analysis From the Early Glycoprotein IIb/IIIa Inhibition in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) Trial , 2011, Circulation.

[265] C. Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2011, Journal of the American College of Cardiology.

[266] Sunil V. Rao,et al. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. , 2011, JACC. Cardiovascular interventions.

[267] H. Katus,et al. Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.

[268] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[269] L. Badano,et al. Usefulness of contrast stress-echocardiography or exercise-electrocardiography to predict long-term acute coronary syndromes in patients presenting with chest pain without electrocardiographic abnormalities or 12-hour troponin elevation. , 2011, The American journal of cardiology.

[270] U. Sechtem,et al. 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. , 2011, Journal of the American College of Cardiology.

[271] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.

[272] Finn Gustafsson,et al. 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[273] S. Werns. Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes , 2011 .

[274] J. Ioannidis,et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes , 2012 .

[275] D. McManus,et al. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. , 2011, The American journal of medicine.

[276] Y. Dundar,et al. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. , 2015, The Cochrane database of systematic reviews.

[277] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[278] F. Eberli,et al. Drug-eluting versus bare-metal stents in large coronary arteries. , 2010, The New England journal of medicine.

[279] A. Greinacher,et al. Thrombocytopenia in the intensive care unit patient. , 2010, Hematology. American Society of Hematology. Education Program.

[280] Charles J. Kahi,et al. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use , 2010, The American Journal of Gastroenterology.

[281] K. Harjai,et al. Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study , 2010, PloS one.

[282] M. Gnant,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010 .

[283] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[284] Deepak L. Bhatt,et al. Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.

[285] G. Montalescot,et al. New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis. , 2010, Journal of the American College of Cardiology.

[286] L. Newby,et al. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry. , 2010, American heart journal.

[287] H. Bruck,et al. Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. , 2010, British journal of clinical pharmacology.

[288] E. Antman,et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. , 2010, JAMA.

[289] James McCord,et al. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. , 2010, Circulation.

[290] E. Antman,et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis , 2010, The Lancet.

[291] S. Yusuf,et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.

[292] G. Stone,et al. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2010, JACC. Cardiovascular interventions.

[293] Jeroen J. Bax,et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[294] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[295] Mike Bradburn,et al. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department , 2010, Heart.

[296] J. Herlitz,et al. Long-term prognostic value of mitral regurgitation in acute coronary syndromes , 2010, Heart.

[297] Sunil V. Rao,et al. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. , 2010, JAMA.

[298] M. Keltai,et al. Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .

[299] Fredrik Folke,et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[300] Mario Plebani,et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[301] S. Stevens,et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial , 2010, European heart journal.

[302] C. Terkelsen,et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. , 2010, JAMA.

[303] T. Edvardsen,et al. Acute coronary occlusion in non-ST-elevation acute coronary syndrome: outcome and early identification by strain echocardiography , 2010, Heart.

[304] P. Gurbel,et al. Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study. , 2010, Journal of the American College of Cardiology.

[305] A. Shuldiner,et al. Genotyping: one piece of the puzzle to personalize antiplatelet therapy. , 2010, Journal of the American College of Cardiology.

[306] R. Kloner,et al. Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension , 2010, Circulation.

[307] L. Wallentin,et al. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. , 2010, American heart journal.

[308] L. Wallentin,et al. Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[309] R. de Caterina,et al. Controversies in cardiovascular medicine Glycaemic control in acute coronary syndromes : prognostic value and therapeutic options , 2010 .

[310] J. McCullough. Overview of platelet transfusion. , 2010, Seminars in hematology.

[311] Deepak L. Bhatt,et al. Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease: Results From the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial , 2010, Circulation.

[312] S. Pocock,et al. A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[313] A. Hall,et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. , 2010, Journal of the American College of Cardiology.

[314] Alan S. Go,et al. Population trends in the incidence and outcomes of acute myocardial infarction. , 2010, The New England journal of medicine.

[315] A. Prasad,et al. Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis , 2010, Herz.

[316] John A Spertus,et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. , 2010, JAMA.

[317] S. Pocock,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[318] T. Kawada,et al. Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease. , 2010, American heart journal.

[319] P. Kirchhof,et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a , 2010, European heart journal.

[320] K. Eagle,et al. The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE , 2010, Heart.

[321] R. Elosua,et al. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. , 2010, Archives of internal medicine.

[322] S. Blankenberg,et al. Copeptin improves early diagnosis of acute myocardial infarction. , 2010, Journal of the American College of Cardiology.

[323] K. Alexander,et al. Minimizing the Risks of Anticoagulants and Platelet Inhibitors , 2010, Circulation.

[324] J. Hodges,et al. CORONARY ARTERY DISEASE Original Studies Patients with Coronary Artery Disease Not Amenable to Traditional Revascularization: Prevalence and 3-Year Mortality , 2010 .

[325] E. Salpeter,et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. , 2010, The Cochrane database of systematic reviews.

[326] James E Tcheng,et al. Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2010, Journal of the American College of Cardiology.

[327] B. Scirica,et al. Acute coronary syndrome: emerging tools for diagnosis and risk assessment. , 2010, Journal of the American College of Cardiology.

[328] E. Vicaut,et al. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. , 2010, American heart journal.

[329] E. Ohman,et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). , 2010, JACC. Cardiovascular interventions.

[330] H. Katus,et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.

[331] P. Serruys,et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. , 2010, Journal of the American College of Cardiology.

[332] S. de Servi,et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. , 2010, British journal of anaesthesia.

[333] S. Z. Abildstrøm,et al. Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. , 2010, European heart journal.

[334] B. Hemmelgarn,et al. Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome. , 2010, American heart journal.

[335] V. Deneer,et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.

[336] S. Yusuf,et al. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[337] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.

[338] S. Yusuf,et al. Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial , 2010, Journal of thrombosis and haemostasis : JTH.

[339] J. Gore,et al. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. , 2010, European heart journal.

[340] K. Alexander,et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.

[341] M. Keltai,et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study , 2010, The Lancet.

[342] P. Nurden,et al. Thrombocytopenia after abciximab use results from different mechanisms , 2010, Thrombosis and Haemostasis.

[343] K. Schulman,et al. Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries , 2010, Circulation.

[344] Á. Avezum,et al. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events , 2009, European heart journal.

[345] R. Sinert,et al. Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome? , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[346] B. Gersh. Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]) , 2010 .

[347] M. Cheitlin. Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes , 2010 .

[348] N. Toma. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of Ticagrelor versus Clopidogrel in patients with stable coronary artery disease. The ONSET/OFFSET study. , 2010, Maedica.

[349] Michael Marber,et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction , 2010 .

[350] E. Topol,et al. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. , 2010, European heart journal.

[351] S. Yusuf,et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. , 2010, European heart journal.

[352] M. Pfeffer,et al. A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[353] Regina M. Hardison,et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.

[354] Gregg W Stone,et al. Platelet inhibition with cangrelor in patients undergoing PCI. , 2009, The New England journal of medicine.

[355] Deepak L. Bhatt,et al. Intravenous platelet blockade with cangrelor during PCI. , 2009, The New England journal of medicine.

[356] L. Køber,et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data , 2009, The Lancet.

[357] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[358] J. Ferrières,et al. Genetic determinants of response to clopidogrel and cardiovascular events. , 2009, The New England journal of medicine.

[359] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[360] S. Yusuf,et al. Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[361] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[362] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[363] S. Verma,et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. , 2009, The Canadian journal of cardiology.

[364] K. Eagle,et al. Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores , 2009, PloS one.

[365] Mark J. Antonino,et al. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease: The ONSET/OFFSET Study , 2009, Circulation.

[366] Sean M. O'Brien,et al. Reoperation for Bleeding in Patients Undergoing Coronary Artery Bypass Surgery: Incidence, Risk Factors, Time Trends, and Outcomes , 2009, Circulation. Cardiovascular quality and outcomes.

[367] W. Markiewicz,et al. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. , 2009, The American journal of cardiology.

[368] E. Antman,et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.

[369] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[370] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[371] E. Antman,et al. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial , 2009, The Lancet.

[372] E. Vicaut,et al. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. , 2009, JAMA.

[373] J. Douketis,et al. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment , 2009, American journal of hematology.

[374] H. Krumholz,et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. , 2009, Journal of the American College of Cardiology.

[375] R. Califf,et al. Sex differences in mortality following acute coronary syndromes. , 2009, JAMA.

[376] E. Antman,et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis , 2009, Journal of the American College of Cardiology.

[377] W. Markiewicz,et al. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction. , 2009, The American journal of cardiology.

[378] D. Liew,et al. Potential survival gains in the treatment of myocardial infarction , 2009, Heart.

[379] G. Finet,et al. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). , 2009, The American journal of cardiology.

[380] W. Baxt,et al. One-year outcomes following coronary computerized tomographic angiography for evaluation of emergency department patients with potential acute coronary syndrome. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[381] S. Yusuf,et al. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines , 2013 .

[382] J. Mega,et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial , 2009, The Lancet.

[383] J. J. Griffin,et al. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. , 2009, JACC. Cardiovascular interventions.

[384] Fred S Apple,et al. A new season for cardiac troponin assays: it's time to keep a scorecard. , 2009, Clinical chemistry.

[385] E. Hannan,et al. Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies , 2009, Circulation.

[386] N. Morgenthaler,et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[387] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[388] Deepak L. Bhatt,et al. Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial , 2009, Circulation.

[389] G. Montalescot,et al. Can we override clopidogrel resistance? , 2009, Circulation.

[390] J. Ware,et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.

[391] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[392] J. Ware,et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2009, Journal of the American College of Cardiology.

[393] Jessica L Mega,et al. Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes , 2009, Circulation.

[394] G. De Luca,et al. Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. , 2009, Journal of the American College of Cardiology.

[395] Fabian Bamberg,et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. , 2009, Journal of the American College of Cardiology.

[396] D. Roberts,et al. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes , 2009 .

[397] G. Mancia,et al. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.

[398] E. Braunwald,et al. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial. , 2009, Journal of the American College of Cardiology.

[399] Sunil V. Rao,et al. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.

[400] S. Pocock,et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[401] D. Angiolillo. Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions , 2009, Diabetes Care.

[402] E. Nagel,et al. Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes , 2009, Circulation.

[403] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[404] H. Bueno,et al. Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. , 2009, The American journal of cardiology.

[405] Adnan Kastrati,et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. , 2009, Journal of the American College of Cardiology.

[406] S. Yusuf,et al. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. , 2009, American heart journal.

[407] A. Kastrati,et al. Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes , 2009, Cardiology.

[408] S. Bélisle,et al. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients , 2009, Current opinion in anaesthesiology.

[409] K. Fox,et al. Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough. , 2009, The American journal of medicine.

[410] G. Montalescot,et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study , 2009, The Lancet.

[411] A. Iskandrian,et al. Takotsubo cardiomyopathy: State-of-the-art review , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[412] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[413] Jens-Uwe Voigt,et al. Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2008, European heart journal.

[414] V. Vaccarino,et al. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. , 2009, Archives of internal medicine.

[415] S. Yusuf,et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. , 2008, European heart journal.

[416] G. Moneta. Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin: A Randomized Trial , 2009 .

[417] A. Elster. Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium–Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial , 2009 .

[418] J. Tijssen,et al. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes , 2008, Heart.

[419] I. Palacios,et al. Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction , 2008, Circulation.

[420] G. Montalescot,et al. Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study. , 2008, JACC. Cardiovascular interventions.

[421] M. Vogelzang,et al. The feasibility and safety of routine thrombus aspiration in patients with non‐ST‐elevation myocardial infarction , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[422] Michael Weis,et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. , 2008, European heart journal.

[423] J. Ware,et al. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2008, JACC. Cardiovascular interventions.

[424] S. Steinhubl,et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. , 2008, Journal of the American College of Cardiology.

[425] R. D. de Winter,et al. A new ECG sign of proximal LAD occlusion. , 2008, The New England journal of medicine.

[426] D. Mark,et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. , 2008, American heart journal.

[427] E. Antman,et al. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 , 2008, Circulation.

[428] D. Mark,et al. Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) , 2008, Journal of cardiovascular electrophysiology.

[429] S. Pocock,et al. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2008, Journal of the American College of Cardiology.

[430] J. Gore,et al. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry , 2008, Nature Clinical Practice Cardiovascular Medicine.

[431] Piotr Pruszczyk,et al. Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .

[432] M. Pfisterer,et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis , 2008, BMJ : British Medical Journal.

[433] R. Cury,et al. Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department , 2008, Circulation.

[434] A. Kastrati,et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. , 2008, The New England journal of medicine.

[435] U. Sechtem,et al. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.

[436] Hyuk-Jae Chang,et al. Usefulness of 64-slice multidetector computed tomography as an initial diagnostic approach in patients with acute chest pain. , 2008, American heart journal.

[437] R. Califf,et al. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. , 2008, European heart journal.

[438] M. Sabatine,et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[439] P. Kolh,et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[440] Sunil V. Rao,et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[441] G. Guyatt,et al. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[442] E. Antman,et al. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. , 2008, Journal of the American College of Cardiology.

[443] M. Fromm,et al. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. , 2008, Journal of the American College of Cardiology.

[444] K. Eagle,et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events , 2008, Heart.

[445] S. Pocock,et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. , 2008, Journal of the American College of Cardiology.

[446] Nader Rifai,et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. , 2008, European heart journal.

[447] M. Keltai,et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial , 2008, The Lancet.

[448] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[449] K. Winters,et al. Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel , 2008, Journal of clinical pharmacology.

[450] J. Eikelboom,et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. , 2008, European heart journal.

[451] J D Hilton,et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) , 2008, Heart.

[452] D. Yuh,et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. , 2008, The Journal of thoracic and cardiovascular surgery.

[453] G. Lip,et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.

[454] A. Kastrati,et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.

[455] P Michael Ho,et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. , 2008, JAMA.

[456] R. Higgins,et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.

[457] J. Menzin,et al. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database* , 2008 .

[458] Á. Avezum,et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. , 2007, European heart journal.

[459] William Wijns,et al. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[460] Deepak L. Bhatt,et al. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. , 2008, American heart journal.

[461] R. Califf,et al. Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial , 2008, Journal of General Internal Medicine.

[462] E. Antman,et al. Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial , 2007, Circulation.

[463] G. Davı̀,et al. Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.

[464] J. Gore,et al. Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? , 2007, Circulation.

[465] J. Ware,et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. , 2007, JAMA.

[466] T. Heer,et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. , 2007, European heart journal.

[467] S. Yusuf,et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. , 2007, JAMA.

[468] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[469] C. Cannon,et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. , 2007, Journal of the American College of Cardiology.

[470] C. Cannon,et al. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. , 2007, The American journal of cardiology.

[471] N. Sarraf-zadegan,et al. Comparison of early dobutamine stress echocardiography and exercise electrocardiographic testing for management of patients presenting to the emergency department with chest pain. , 2007, The American journal of cardiology.

[472] Jeroen J. Bax,et al. Universal definition of myocardial infarction. , 2007 .

[473] Shah Ebrahim,et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[474] S. Yusuf,et al. Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in NonST-Segment Elevation Acute Coronary Syndromes , 2007, Annals of Internal Medicine.

[475] R. Virmani,et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. , 2007, Journal of the American College of Cardiology.

[476] E. Antman,et al. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. , 2007, European heart journal.

[477] C. Poole,et al. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality , 2007, Heart.

[478] Christopher P Cannon,et al. Diabetes and mortality following acute coronary syndromes. , 2007, JAMA.

[479] W. Gibler,et al. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. , 2007, The American journal of medicine.

[480] J. Jukema,et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. , 2007, American heart journal.

[481] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[482] Simon Capewell,et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[483] Á. Avezum,et al. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE). , 2007, American heart journal.

[484] A. Yan,et al. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. , 2007, Archives of internal medicine.

[485] M. Naylor,et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[486] K. Eagle,et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. , 2007, JAMA.

[487] K. Alexander,et al. Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. , 2007, Journal of the American College of Cardiology.

[488] Timothy J Gardner,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.

[489] A. Skene,et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. , 2007, JAMA.

[490] B. Lewis,et al. Usefulness of 64-Slice Cardiac Computed Tomographic Angiography for Diagnosing Acute Coronary Syndromes and Predicting Clinical Outcome in Emergency Department Patients With Chest Pain of Uncertain Origin , 2007, Circulation.

[491] J. Ware,et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial , 2007, The Lancet.

[492] T. Warkentin,et al. Focus on Research: Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis , 2007 .

[493] R. Califf,et al. Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome , 2007, Circulation.

[494] Deepak L. Bhatt,et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? , 2007, Journal of the American College of Cardiology.

[495] William W O'Neill,et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. , 2007, Journal of the American College of Cardiology.

[496] W. B. Meijboom,et al. 64-Slice CT coronary angiography in patients with non-ST elevation acute coronary syndrome , 2007, Heart.

[497] J. Ware,et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.

[498] V. Fuster,et al. Normalization of platelet reactivity in clopidogrel‐treated subjects , 2007, Journal of thrombosis and haemostasis : JTH.

[499] K. Eagle,et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events , 2006, Heart.

[500] P. Serruys,et al. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. , 2006, European heart journal.

[501] F. Van de Werf,et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) , 2005, Heart.

[502] Renu Virmani,et al. Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[503] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[504] Huiman Barnhart,et al. Correction of anemia with epoetin alfa in chronic kidney disease. , 2006, The New England journal of medicine.

[505] F. Neumann,et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. , 2006, Journal of the American College of Cardiology.

[506] L. Wallentin,et al. Gender differences in management and outcome in non-ST-elevation acute coronary syndrome , 2006, Heart.

[507] F. Burzotta,et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. , 2006, European heart journal.

[508] A. Kastrati,et al. Impact of P‐glycoprotein on clopidogrel absorption , 2006, Clinical pharmacology and therapeutics.

[509] K. Eagle,et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.

[510] Deepak L. Bhatt,et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. , 2006, Journal of the American College of Cardiology.

[511] G. Filippatos,et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. , 2006, European heart journal.

[512] Harald Langer,et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. , 2006, European heart journal.

[513] K. Alexander,et al. Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative , 2006, Circulation.

[514] Harlan M Krumholz,et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. , 2006, Archives of internal medicine.

[515] T. Villines,et al. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[516] L. Wallentin,et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study , 2006, The Lancet.

[517] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. , 2006, The New England journal of medicine.

[518] Young‐Bae Park,et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[519] G. Montalescot,et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. , 2006, Journal of the American College of Cardiology.

[520] S. Yusuf,et al. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes , 2006, Circulation.

[521] S. Yusuf,et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.

[522] L. Rydén,et al. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart , 2006, Heart.

[523] I. Scott,et al. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. , 2006, The Cochrane database of systematic reviews.

[524] C. Cannon,et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. , 2006, Journal of the American College of Cardiology.

[525] T. Heer,et al. Gender differences in acute non-ST-segment elevation myocardial infarction. , 2006, The American journal of cardiology.

[526] R. Bugiardini,et al. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. , 2006, Archives of internal medicine.

[527] N. Doll,et al. Emergency Coronary Artery Bypass Graft Surgery for Acute Coronary Syndrome: Beating Heart Versus Conventional Cardioplegic Cardiac Arrest Strategies , 2006, Circulation.

[528] P. Monteiro. Impact of Early Coronary Artery Bypass Graft in an Unselected Acute Coronary Syndrome Patient Population , 2006, Circulation.

[529] W. Gibler,et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Ini , 2006, American heart journal.

[530] L. Køber,et al. Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction , 2006, Circulation.

[531] M. Tonelli,et al. Prophylaxis strategies for contrast-induced nephropathy. , 2006, JAMA.

[532] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.

[533] J. Critchley,et al. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[534] G. Mancia,et al. Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. , 2006, European heart journal.

[535] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[536] M. Pfeffer,et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.

[537] P. Armstrong,et al. Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment. , 2006, The Canadian journal of cardiology.

[538] P. Sandset,et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. , 2006, European heart journal.

[539] J. Borer. Therapeutic effects of I(f) blockade: evidence and perspective. , 2006, Pharmacological research.

[540] P. Steg,et al. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. , 2006, Archives of internal medicine.

[541] Salim Yusuf,et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.

[542] S. Yusuf,et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.

[543] A. Kastrati,et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. , 2006, JAMA.

[544] N. Geller,et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. , 2006, Journal of the American College of Cardiology.

[545] M. Simoons,et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. , 2006, European heart journal.

[546] L. Newby,et al. Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative). , 2006, The American journal of cardiology.

[547] J. Camm,et al. [Guidelines on the management of stable angina pectoris: executive summary]. , 2006, Giornale italiano di cardiologia.

[548] M. Mack,et al. Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass. , 2006, The Journal of thoracic and cardiovascular surgery.

[549] Z. Babić,et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. , 2006, European heart journal.

[550] K. Alexander,et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[551] R. Collins,et al. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[552] F. Van de Werf,et al. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. , 2005, European heart journal.

[553] L. Wallentin,et al. Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[554] R. Storey,et al. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses , 2005, Platelets.

[555] Lisa Hartling,et al. Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.

[556] S. Urien,et al. Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis. , 2005, British journal of clinical pharmacology.

[557] K. Eagle,et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. , 2005, The American journal of cardiology.

[558] J. Tijssen,et al. Early invasive versus selectively invasive management for acute coronary syndromes. , 2005, The New England journal of medicine.

[559] S. Kaul,et al. Myocardial contrast echocardiography versus Thrombolysis In Myocardial Infarction score in patients presenting to the emergency department with chest pain and a nondiagnostic electrocardiogram. , 2005, Journal of the American College of Cardiology.

[560] W. Ageno,et al. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves. , 2005, Journal of the American College of Cardiology.

[561] H. Boshuizen,et al. Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review , 2005, Circulation.

[562] J. Spertus,et al. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. , 2005, The American journal of cardiology.

[563] A. Parkhomenko,et al. Recommendations for the structure, organization, and operation of intensive cardiac care units. , 2005, European heart journal.

[564] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[565] Darren K Mcguire,et al. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. , 2005, European heart journal.

[566] S. Yusuf,et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.

[567] B. Gersh,et al. Methods of coronary revascularization--things may not be as they seem. , 2005, The New England journal of medicine.

[568] Carlos Aguiar,et al. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. , 2005, European heart journal.

[569] C. Terkelsen,et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. , 2005, European heart journal.

[570] R. Giugliano,et al. Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes , 2005, Circulation.

[571] G. Stone,et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.

[572] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[573] J. Herbert,et al. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. , 2005, Seminars in thrombosis and hemostasis.

[574] S. Yusuf,et al. Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial , 2005, Circulation.

[575] L. Newby,et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/Ameri , 2005, Journal of the American College of Cardiology.

[576] P. Corso,et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? , 2005, European heart journal.

[577] W. Markiewicz,et al. Fasting Glucose Is an Important Independent Risk Factor for 30-Day Mortality in Patients With Acute Myocardial Infarction: A Prospective Study , 2005 .

[578] A. Cohen-Solal,et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[579] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[580] W. Ghali,et al. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. , 2005, The American journal of cardiology.

[581] K. Swedberg,et al. [Expert Consensus document on beta-adrenergic receptor blockers]. , 2004, Revista espanola de cardiologia.

[582] G. Flaker,et al. Improved anticoagulation with a weight-adjusted heparin nomogram in patients with acute coronary syndromes: A randomized trial , 1995, Journal of Thrombosis and Thrombolysis.

[583] W. Geerts,et al. Anticoagulant Use in Patients with Chronic Renal Impairment , 2005, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[584] C. Cannon,et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes , 2004 .

[585] L. Stitt,et al. Does clopidogrel increase blood loss following coronary artery bypass surgery? , 2004, The Annals of thoracic surgery.

[586] V. Boyko,et al. The Outcome of Coronary Artery Bypass Grafting Surgery among Patients Hospitalized with Acute Coronary Syndrome: The Euro Heart Survey of Acute Coronary Syndrome Experience , 2004, Cardiology.

[587] L. Rydén,et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. , 2004, European heart journal.

[588] R. Califf,et al. Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young , 2004, Circulation.

[589] M. Tonelli,et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[590] J. Golmard,et al. Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes , 2004, Circulation.

[591] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[592] S. Yusuf,et al. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.

[593] P. Poole‐Wilson,et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial , 2004, The Lancet.

[594] J. Hirsh,et al. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[595] S. Steinhubl,et al. Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic Complications: Analysis of 4 Recent Randomized Clinical Trials of Percutaneous Coronary Intervention , 2004, Circulation.